This section has no associated Explanatory Memorandum
300. Commission Implementing Regulation (EU) 2017/1527 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances cyflufenamid, fluopicolide, heptamaloxyloglucan and malathion.